Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,966 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Anakinra Pilot - a clinical trial to demonstrate safety, feasibility and pharmacokinetics of interleukin 1 receptor antagonist in preterm infants.
Green EA, Metz D, Galinsky R, Atkinson R, Skuza EM, Clark M, Gunn AJ, Kirkpatrick CM, Hunt RW, Berger PJ, Nold-Petry CA, Nold MF. Green EA, et al. Among authors: clark m. Front Immunol. 2022 Oct 27;13:1022104. doi: 10.3389/fimmu.2022.1022104. eCollection 2022. Front Immunol. 2022. PMID: 36389766 Free PMC article. Clinical Trial.
Obstructive Bilateral Renal Fungal Bezoars in an Extremely Premature Neonate Treated With Antifungals and Urokinase Irrigation: A Case Report and Review of the Literature.
Davis K, Yap N, Clark M, Bhatia R, Johnstone L, Taghavi K, O'Brien M, Ching N, Carr J. Davis K, et al. Among authors: clark m. Pediatr Infect Dis J. 2025 Jan 1;44(1):64-68. doi: 10.1097/INF.0000000000004505. Epub 2024 Aug 7. Pediatr Infect Dis J. 2025. PMID: 39163305 Free PMC article. Review.
TP53 Mutations are Associated with CD19 Negative Relapse and Inferior Outcomes after Blinatumomab in Adults with ALL.
Aldoss I, Li S, Zhang J, Clark MC, Agrawal V, Pourhassan H, Koller PB, Aribi A, Ali H, Blackmon A, Otoukesh S, Sandhu KS, Ball BJ, Arslan S, Artz AS, Amanam I, Al Malki MM, Salhotra A, Kovacsovics TJ, Murphy LA, Afkhami M, Ngo D, Tinajero J, Gu Z, Becker PS, Nakamura R, Stein AS, Marcucci G, Forman SJ, Pullarkat VA. Aldoss I, et al. Among authors: clark mc. Blood Adv. 2025 Jan 16:bloodadvances.2024014986. doi: 10.1182/bloodadvances.2024014986. Online ahead of print. Blood Adv. 2025. PMID: 39820649
Multiclass Synthetic Accessibility Prediction.
Li X, Walsh R, Abbas W, Pascual-Diaz S, Hand C, Garland R, Khan FM, Mohan Das N, Desai V, AbouZleikha M, Clark MA. Li X, et al. Among authors: clark ma. J Chem Inf Model. 2025 Jan 17. doi: 10.1021/acs.jcim.4c01663. Online ahead of print. J Chem Inf Model. 2025. PMID: 39818777
Optimizing Exposure Measures in Large-Scale Household Air Pollution Studies: Results from the Multicountry HAPIN Trial.
Steenland K, Pillarisetti A, Johnson M, Rosenthal J, Balakrishnan K, Underhill L, Thompson L, McCracken J, Waller L, Nicolaou L, Clark M, Checkley W, Peel J, Clasen T. Steenland K, et al. Among authors: clark m. Environ Sci Technol. 2025 Jan 14. doi: 10.1021/acs.est.4c08052. Online ahead of print. Environ Sci Technol. 2025. PMID: 39807776
5,966 results